Searched over 200M research papers for "chronic infectious"
10 papers analyzed
These studies suggest chronic infections can significantly alter immune system functions, are linked to numerous chronic conditions, and may require targeted public health interventions and novel treatment strategies.
19 papers analyzed
Chronic viral infections are a significant part of our virome, the collection of viruses that inhabit our bodies. These infections persist due to a dynamic equilibrium between the virus and the host's immune system, which continuously works to control the virus while avoiding damage to the host tissues. This balance can be benign, harmful, or even symbiotic, influencing how we understand and treat chronic inflammatory diseases and how we approach genome-wide association studies and vaccination strategies.
Chronic viral infections lead to continuous stimulation of both the innate and adaptive immune systems. This persistent activation results in significant changes, including reduced levels of type I interferons, exhaustion of CD8(+) T cells, and specialization of CD4(+) T cells to support antibody-mediated immunity. These adaptations are driven by epigenetic, transcriptional, and metabolic changes, aiming to maintain a balance between the host and the virus, albeit often imperfectly.
Chronic HBV infection is a major global health issue, leading to severe conditions like cirrhosis and liver cancer. The risk of developing chronic HBV infection is highest among neonates born to HBV-positive mothers, with a significant risk also present in children infected before the age of six. In adults, the risk of chronicity is generally low, but it increases in individuals with compromised immune systems. Despite a decrease in HBV prevalence in many regions due to expanded immunization, the absolute number of chronically infected individuals has increased, highlighting the need for targeted health policies.
Chronic active EBV infection, also known as chronic infectious mononucleosis, is characterized by persistent fatigue and other symptoms. Patients with this condition exhibit a unique immune dysfunction, where T cells suppress the immune response, correlating with high levels of EBV-specific antibodies. This state mirrors a temporary phase seen during recovery from acute EBV infection, suggesting a prolonged immune response in chronic cases.
Chronic infections with pathogens like helminths, mycobacteria, and hepatitis viruses can modulate the immune response to unrelated antigens, affecting susceptibility to other infections and vaccine efficacy. These bystander infections influence various stages of the immune response, from pathogen recognition to the development of immunological memory, necessitating a deeper understanding to improve vaccine strategies and disease control.
Certain chronic bacterial infections, such as tuberculosis and cystic fibrosis-associated lung infections, are challenging to treat due to the presence of persister cells. These cells are a small, drug-tolerant subpopulation that can survive antibiotic treatment, leading to persistent infections. Understanding the mechanisms behind persister cell formation is crucial for developing effective anti-persister therapies.
Chronic infectious diseases pose a complex challenge due to their persistent nature and the intricate interplay with the host's immune system. Understanding the mechanisms of immune regulation, the role of persister cells, and the impact of chronic infections on overall immunity is essential for developing effective treatments and public health strategies. By focusing research efforts on these areas, we can mitigate the human, economic, and societal burden of chronic infectious diseases.
Most relevant research papers on this topic